Table 2 Hemodynamic and laboratory analysis parameters of osteoarthritis patients and healthy controls
From: Increased arterial stiffness in patients with end-stage osteoarthritis: a case-control study
Variable | Osteoarthritis patients (n = 48) | Controls (n = 49) | p-value |
|---|---|---|---|
Peripheral SBP (mm Hg) | 133.6 ± 17.8 | 128.3 ± 18.9 | 0.158 |
Peripheral DBP (mm Hg) | 80.8 ± 7.5 | 78.9 ± 9.0 | 0.269 |
AIx@HR75 (%) | 25.0 ± 8.1 | 22.8 ± 9.4 | 0.213 |
PP amplification (%) | 123 ± 11 | 124 ± 13 | 0.879 |
Central SBP (mm Hg) | 125.2 ± 17.0 | 120.5 ± 18.8 | 0.205 |
Central DBP (mm Hg) | 81.5 ± 8.2 | 79.8 ± 9.3 | 0.373 |
Mean pressure (mm Hg) | 99.6 ± 10.9 | 96.6 ± 12.2 | 0.209 |
Heart rate (bpm) | 64.8 ± 7.1 | 63.2 ± 7.3 | 0.279 |
car-fem PWV (m/s) | 9.6 ± 2.4 | 8.4 ± 1.9 | 0.015 |
car-rad PWV (m/s) | 8.7 ± 1.1 | 8.4 ± 1.1 | 0.235 |
C1 (ml/mmHg × 100) | 12.5 ± 4.2 | 12.7 ± 3.5 | 0.371 |
C2 (ml/mmHg × 100) | 4.5 ± 2.9 | 5.6 ± 4.3 | 0.315 |
Triglycerides (mmol/l) | 1.7 ± 0.8 | 1.4 ± 0.7 | 0.021 |
LDL- cholesterol (mmol/l) | 4.1 ± 1.0 | 3.8 ± 1.0 | 0.234 |
HDL- cholesterol (mmol/l) | 1.5 ± 0.5 | 1.7 ± 0.5 | 0.830 |
Total cholesterol (mmol/l) | 6.0 ± 1.1 | 6.0 ± 1.3 | 0.264 |
Glucose (mmol/l) | 5.8 ± 0.7 | 5.7 ± 0.4 | 0.566 |
hsCRP (mg/l) | 1.80 ± 1.10 | 1.48 ± 1.32 | 0.042 |
Urea (mmol/l) | 5.9 ± 2.0 | 5.3 ± 1.3 | 0.171 |
eGFR (ml/mg/1.73 m2) | 83 ± 20 | 82 ± 12 | 0.434 |
White blood cells (109/L) | 6.5 ± 1.5 | 5.6 ± 1.9 | 0.001 |
Plateletes (109/L) | 243 ± 52 | 222 ± 39 | 0.053 |